Library / Research areas / Heart & blood
Heart & blood
Peptides used or studied in cardiovascular care and blood clotting.
These compounds are grouped by what they are studied for. Being studied for something is not the same as being proven to work, or safe. Compounds are listed from the strongest human evidence to the weakest.
Approved use · Regulator-approved for a specific indication
Angiotensin II
Approved Peptide Medicines
8residues
1,046daltons
Evidence: Approved use
Eptifibatide
Approved Peptide Medicines
7residues
832daltons
Evidence: Approved use
Terlipressin
Approved Peptide Medicines
12residues
1,227daltons
Evidence: Approved use
Bivalirudin
Approved Peptide Medicines
20residues
2,180.3daltons
Evidence: Approved use
Dulaglutide
Metabolic Research
Largeprotein
63,000daltons
Evidence: Approved use
SS-31 (Elamipretide)
Mitochondrial & Longevity
4residues
639.8daltons
Evidence: Approved use
Semaglutide
Metabolic Research
31residues
4,113.6daltons
Evidence: Approved use
Vasopressin
Neuroscience
9residues
1,084.2daltons
Evidence: Approved use
Controlled trials · Randomized trials with clinical endpoints
Aprotinin
Approved Peptide Medicines
58residues
6,511daltons
Evidence: Controlled trials
Desirudin
Approved Peptide Medicines
63residues
6,963daltons
Evidence: Controlled trials
Nesiritide
Approved Peptide Medicines
32residues
3,464daltons
Evidence: Controlled trials
Other research areas
Weight & metabolismEnergy & mitochondriaSleepRecovery & repairGrowth hormoneBrain & moodImmunitySkin & hairLongevity & agingSexual & reproductive healthHormones & bone
Educational reference only. Nothing here is medical advice, a treatment recommendation, or dosing or sourcing guidance.